إعلان
إعلان

PRPH

PRPH logo

ProPhase Labs, Inc. Common Stock (DE)

0.45
USD
برعاية
0.00
-0.89%
٣٠ ديسمبر, ١٥:٥٢ UTC -5
مغلق
exchange

قبل الإفتتاح

0.45

0.00
-0.95%

تقارير أرباح PRPH

النسبة الإيجابية المفاجئة

PRPH تفوق 8 من 19 آخر التقديرات.

42%

التقرير التالي

بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$9.86M
/
-$0.12
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
-497.08%
/
-99.25%

ProPhase Labs, Inc. Common Stock (DE) earnings per share and revenue

On ١٧ نوفمبر ٢٠٢٥, PRPH reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.11 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.80 مليون, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.12 USD, with revenue projected to reach 9.86 مليون USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, ProPhase Labs, Inc. Common Stock (DE) reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
Based on 3 analysts, ProPhase Labs, Inc. Common Stock (DE) is expected to report EPS of -$0.12 and revenue of $9.86M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان